SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Schiehalli. Regulatory News (MNTN)

Share Price Information for The Schiehalli. (MNTN)

Share Price is delayed by 15 minutes
Get Live Data
2.17    0.02 (0.93%)
Bid:
2.18
Ask:
2.20
Spread: 0.02 (0.917%)
Market Cap: $2.23b
MNTN Live PriceLast checked at - London Stock Exchange

Intraday The Schiehalli. Share Chart

C Share Conversion Ratio

7 Sep 2023 12:25

RNS Number : 7522L
Schiehallion Fund Limited (The)
07 September 2023
 

The Schiehallion Fund Limited

(the "Company")

Legal Entity Identifier: 213800NQOLJA1JCWXQ56

C Share Conversion Ratio

Further to the announcement on 3 August 2023, the Company is pleased to announce the Conversion Ratio on the basis of the respective Net Asset Values of the Ordinary Shares and the C Shares as at the Conversion Calculation Date, being 31 August 2023.

 

 

Net Asset Value per Ordinary Share

106.14 cents

Net Asset Value per C Share

80.68 cents

Conversion Ratio

0.7601 Ordinary shares for each C Share

 

 

The number of New Ordinary Shares to be issued as a result of Conversion will be calculated based on the register at 6.00 p.m. on 8 September 2023 and is expected to be announced on 11 September 2023. The holders of C Shares will not be entitled to fractions of New Ordinary Shares arising on Conversion. Instead, the number of New Ordinary Shares to be issued to each holder will be rounded down to the nearest whole number of Ordinary Shares and fractional entitlements will be disregarded, with any value attributable to them being retained for the benefit of the Company. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares, including the right to receive all future dividends or distributions declared in respect of the Ordinary Shares.

 

Application has been made for the New Ordinary Shares to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange's Main Market ("Admission"). It is now expected that admission will become effective and that dealings in the New Ordinary Shares will commence at 8:00 a.m. on 12 September 2023 (rather than 11 September 2023, as indicated in the announcement on 3 August 2023).

 

Application will also be made to cancel the C Shares from trading on the London Stock Exchange as soon as reasonably practicable following Conversion.

 

 

 

Expected timetable

 

Event

Date

Conversion record date

6:00 p.m. on 8 September 2023

Cancellation of C Shares

As soon as reasonably practicable following conversion

Admission of new Ordinary Shares on Conversion and dealings commence

 

8:00 a.m. on 12 September 2023

Crediting of CREST accounts with new Ordinary Shares

12 September 2023

Share Certificates in respect of new Ordinary Shares despatched

w/c 18 September 2023

 

 

Capitalised terms used but not defined in this announcement will have the same meaning as set out in the Prospectus.

 

 

 

 

Baillie Gifford & Co Limited

7 September 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBUAROUUKRAR
Date   Source Headline
10th Jun 202612:20 pmRNSNet Asset Value(s)
10th Jun 202612:20 pmRNSUpdate on NAV and Bending Spoons Valuation
4th Jun 20263:46 pmRNSNet Asset Value(s)
4th Jun 20263:45 pmRNSUpdate on NAV and SpaceX Valuation
2nd Jun 20269:56 amRNSDirector Appointment
1st Jun 202612:46 pmRNSNet Asset Value(s)
1st Jun 202610:22 amRNSTotal Voting Rights
29th May 20265:05 pmRNSIssue of Equity
29th May 20262:05 pmRNSIssue of Equity
26th May 20264:24 pmRNSIssue of Equity
22nd May 20264:44 pmRNSIssue of Equity
22nd May 20264:14 pmRNSIssue of Equity
19th May 20263:33 pmRNSIssue of Equity
14th May 20263:33 pmRNSResult of AGM
1st May 20262:49 pmRNSNet Asset Value(s)
1st May 20269:50 amRNSTotal Voting Rights
27th Apr 202612:40 pmRNSUpdate on NAV and Anthropic valuation
27th Apr 202612:26 pmRNSNet Asset Value(s)
16th Apr 202611:28 amRNSNet Asset Value(s)
14th Apr 20264:55 pmRNSIssue of Equity
10th Apr 20264:48 pmRNSIssue of Equity
10th Apr 20261:47 pmRNSIssue of Equity
9th Apr 20264:37 pmRNSIssue of Equity
8th Apr 20267:00 amRNSSchiehallion Fund Annual Financial Report
7th Apr 20264:38 pmRNSIssue of Equity
1st Apr 20264:36 pmRNSUpdate on NAV and SpaceX valuation
1st Apr 20264:22 pmRNSNet Asset Value(s)
2nd Mar 20261:43 pmRNSNet Asset Value(s)
2nd Mar 202610:30 amRNSTotal Voting Rights
26th Feb 20264:18 pmRNSIssue of Equity
2nd Feb 20264:01 pmRNSClosed Period Confirmation
2nd Feb 20263:39 pmRNSNet Asset Value(s)
2nd Jan 20261:39 pmRNSNet Asset Value(s)
2nd Jan 202611:23 amRNSBlock listing Interim Review
16th Dec 202512:32 pmRNSUpdate on NAV and SpaceX valuation
16th Dec 202512:31 pmRNSNet Asset Value(s)
10th Dec 20258:00 amRNSReadmission - THE SCHIEHALLION FUND LIMITED
8th Dec 202510:57 amRNSResult of General Meeting
1st Dec 20251:20 pmRNSNet Asset Value(s)
1st Dec 202510:26 amRNSTotal Voting Rights
1st Dec 202510:10 amRNSProxy Advisor Recommendation Clarification
25th Nov 20254:37 pmRNSTransaction in Own Shares
21st Nov 20254:19 pmRNSTransaction in Own Shares
18th Nov 20254:41 pmRNSTransaction in Own Shares
12th Nov 20254:44 pmRNSTransaction in Own Shares
11th Nov 202510:55 amRNSPublication of Circular and Notice of EGM
10th Nov 20254:38 pmRNSTransaction in Own Shares
5th Nov 20254:35 pmRNSTransaction in Own Shares
3rd Nov 20251:55 pmRNSNet Asset Value(s)
3rd Nov 202510:38 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.